Showing posts with label Clinicians. Show all posts
Showing posts with label Clinicians. Show all posts

Thursday, March 26, 2015

COCA Call Today: Disaster/Emergency Preparedness For Clinicians

image

Credit CDC

 

# 9865

 

A reminder that today:  March 26, 2015 at 2:00pm EST, the CDC will hold a COCA call on disaster and emergency preparedness for clinicians.

 

Emergency Preparedness for Clinicians - From Guidelines to the Front Line

Image of Continuing Education Credits abbreviation. = Free Continuing Education

Date:Thursday, March 26, 2015

Time:2:00 – 3:00 PM (Eastern Time)

Participate by Phone:

  • 888-323-9813 (U.S. Callers)
  • 212-547-0291 (International Callers)

Passcode:3257688

Participate by Webinar:https://www.mymeetings.com/nc/join.php?i=PW1955511&p=3257688&t=c

Presenter(s)

Michael D. Christian, MD, MSc
Chief Safety Officer
Vice Chair, Disaster Network
Niagara Health System

Niranjan (Tex) Kissoon, MD, FRCPC, FAAP, MCCM, FACPE
Vice President, Medical Affairs
BC Children’s Hospital
Professor, Pediatric and Surgery
University of British Columbia
Vancouver, BC

Lewis Rubinson, MD, PhD, FCCP
Associate Professor
University of Maryland School of Medicine
Director of the Critical Care Resuscitation Unit
R Adams Cowley Shock Trauma Center

Timothy Uyeki, MD, MPH, MPP
Chief Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Clinical Team Lead, Ebola Response
Centers for Disease Control and Prevention

Overview

Natural disasters, industrial accidents, terrorism attacks, and pandemics all have the capacity to result in large numbers of critically ill or injured patients. A barrage of patients with various clinical needs can quickly exhaust the care delivery capacity of a healthcare system. It is important for clinicians to have a disaster response plan that addresses approaches to maintaining quality care during times of patient surge and resource scarcity. During this COCA Call, participants will learn about the series of suggestions that focus on the management of multiple critically ill patients during a disaster or pandemic, and the importance of collaboration among front-line clinicians, hospital administrators, professional societies, and public health or government officials.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  • Outline the five main levels of disaster preparedness and response from the American College of Chest Physicians’ Guidelines for Care of the Critically Ill and Injured during Pandemics and Disasters
  • Discuss the importance of pediatric emergency preparedness for both pediatric and non-pediatric providers
  • Identify key lessons learned from the recent Ebola outbreak for improving emergency preparedness in North American
  • Describe ways clinicians and public health practitioners can collaborate to respond to disasters and pandemics
Additional Resources

 

 

While primarily of interest to healthcare providers, COCA (Clinician Outreach Communication Activity) calls are designed to ensure that practitioners have up-to-date information for their practices.  The audio from these calls are posted several days after they are held.  You can access COCA calls going back to 2012 at this link.

Monday, August 11, 2014

CDC Guidance: Ebola Disease Information For Clinicians In U.S.

image
Credit CDC PHIL

 


# 8938

 

The CDC continues to roll out new guidance and information on Ebola for Health Care and other sectors, with the most recent posted yesterday on their Ebola Information website:

 

Ebola Virus Disease Information for Clinicians in U.S. Healthcare Settings

The Centers for Disease Control and Prevention is working closely with the World Health Organization and other partners to better understand and manage the public health risks posed by Ebola virus disease (EVD). As of August 10, 2014, no EVD cases have occurred in the United States. The purpose of this document is to provide updated information about EVD to clinicians working in U.S. hospitals and health clinics.

Clinical Presentation and Clinical Course

Patients with EVD generally have abrupt onset of typically 8-10 days after exposure (mean 4-10 days in previous outbreaks, range 2-21 days).  Initial signs and symptoms are nonspecific and may include fever, chills, myalgias, and malaise. Fever, anorexia, asthenia/weakness are the most common signs and symptoms. Patients may develop a diffuse erythematous maculopapular rash by day 5 to 7 (usually involving the face, neck, trunk, and arms) that can desquamate.

Due to these nonspecific symptoms particularly early in the course, EVD can often be confused with other more common infectious diseases such as malaria, typhoid fever, meningococcemia, and other bacterial infections (e.g., pneumonia). 

Patients can progress from the initial non-specific symptoms after about 5 days to develop gastrointestinal symptoms such as severe watery diarrhea, nausea, vomiting and abdominal pain. Other symptoms such as chest pain, shortness of breath, headache or confusion, may also develop.  Patients often have conjunctival injection.  Hiccups have been reported.  Seizures may occur, and cerebral edema has been reported.  Bleeding is not universally present but can manifest later in the course as petechiae, ecchymosis/bruising, or oozing from venipuncture sites and mucosal hemorrhage. Frank hemorrhage is less common.  Pregnant women may experience spontaneous miscarriages.

Patients with fatal disease usually develop more severe clinical signs early during infection and die typically between days 6 and 16 of complications including multi-organ failure and septic shock. In non-fatal cases, patients may have fever for several days and improve, typically around day 6-11. Patients that survive can have a prolonged convalescence. The World Health Organization has estimated the mortality of the current outbreak of EVD in West Africa to be approximately 55%, but appears to be as high as 75% in Guinea.

(Continue . . . .)

 

You will also find additional sections dealing with:

 

You can find more CDC guidance documents at http://www.cdc.gov/vhf/ebola/outbreaks/guinea/whats-new.html

Saturday, December 21, 2013

Texas DSHS Letter To Doctors On Influenza Outbreak

image

Credit Texas Influenza Weekly Surveillance

 

# 8097

 

While some in the media this week are hyping the recent influenza deaths in Texas (see Texas DSHS Statement On Recent Spike In Flu Activity) as the `Return of Swine Flu’, the reality is, the virus never left.

 

It has been with us since it first emerged in 2009, but has taken a backseat to the other seasonal strain - H3N2 - in North America over the past couple of years.

 

While H1N1 is no longer a pandemic virus, it can still pack a punch . . . particularly for those under the age of 65, and those with pre-existing medical conditions.  And since it hasn’t been the dominant strain in North America the past couple of years, many people have reduced immunity to it (particularly if they skipped the flu shot).

 

This week we’ve seen reports of multiple deaths in Texas, and around the nation, now attributed to the H1N1 virus.  Many others have been hospitalized with severe illness.

 

Yesterday, the Texas DSHS sent out a notice to doctors and hospitals advising them on how to test for, and treat, severe cases of flu.

 

TEXAS DEPARTMENT OF STATE HEALTH SERVICES
DAVID L. LAKEY, M.D.  COMMISSIONER
www.dshs.state.tx.us

**INFLUENZA HEALTH ALERT**


December 20, 2013


Dear Colleague: 


Statewide influenza-like illness (ILI) activity continues to increase and is above baseline levels. ILI intensity is high in Texas, and influenza is now widespread. All Texas regions have reported laboratory confirmed influenza. Over 90% of positive influenza tests reported from Texas laboratories have been typed as influenza A. Of those influenza A viruses that have been subtyped, 90% have been the 2009 pandemic H1N1 subtype. This subtype of influenza is included in this season's influenza vaccine. 

No novel influenza cases have been reported in Texas. 


No antiviral resistant influenza strains have been reported in Texas. 


Encourage patients to get vaccinated for influenza. 


Clinicians should consider antivirals even if the Rapid Influenza Diagnostic Test is negative. 

Background: Influenza viruses can be spread by large respiratory droplets generated when an infected person coughs or sneezes in close proximity to an uninfected person. Symptoms can include fever, dry cough, sore throat, headache, body aches, fatigue, and nasal congestion. Among children, otitis media, nausea, vomiting, and diarrhea are common.

Most people generally recover from illness in 1-2 weeks, but some people develop complications and may die from influenza. The highest rates of influenza infection occur among children; however, the risks for serious health problems, hospitalizations, and deaths from influenza are higher among people 65 years of age or older, very young children, and people of any age who have medical  conditions that place them at increased risk for complications from influenza (see Treatment). 


Vaccination: Everyone who is at least 6 months of age should get a flu vaccine this season. It is not too late for vaccination. There are several flu vaccine options available for the 2013-2014 flu season. All these vaccines contain the currently circulating H1N1 strain. DSHS does not recommend one flu vaccine over another, although there are special indications for some (such as a high-dose inactivated trivalent vaccine approved for persons age 65 years and older). 

The 2013-2014 trivalent influenza vaccine is made from the following three

  An A/California/7/2009 (H1N1)pdm09-like virus 
  An A(H3N2) virus antigenically like the cell-propagated prototype virus A
  A B/Massachusetts/2/2012-like virus

Rapid Lab Tests: Rapid Influenza Diagnostic Tests (RIDTs) can be useful to identify influenza virus infection, but false negative test results are common during influenza season. Clinicians should be aware that a negative RIDT result does NOT exclude a diagnosis of influenza in a patient with suspected influenza. When there is clinical suspicion of influenza and antiviral treatment is indicated, antiviral treatment should be started as soon as possible, even if the result of the RIDT is negative, without waiting for results of additional influenza testing. 


Treatment: Oseltamivir and zanamivir are chemically related antiviral medications known as neuraminidase inhibitors that have activity against both influenza A and B viruses. Early antiviral treatment can shorten the duration of fever and illness symptoms, may reduce the risk of complications and death, and may shorten the duration of hospitalization. Clinical benefit is greatest when antiviral treatment is administered early, especially within 48 hours of influenza illness onset. Decisions about starting antiviral treatment should not wait for laboratory confirmation of influenza. 


Antiviral treatment is recommended as early as possible for any patient with confirmed or suspected influenza who:


  Is hospitalized.
  Has severe, complicated, or progressive illness. 
  Is at higher risk for influenza complications. 

Persons at higher risk for influenza complications recommended for antiviral treatment include: 


  Children aged younger than 2 years.
  Adults aged 65 years and older. 
  Persons with chronic pulmonary (including asthma), cardiovascular (except hypertension alone), renal, hepatic, or hematological disease (including sickle cell disease); metabolic disorders (including diabetes mellitus); or neurologic and neurodevelopment conditions (including disorders of the brain, spinal cord, peripheral nerve, and muscle such as cerebral palsy, epilepsy [seizure disorders], stroke, intellectual disability [mental retardation], moderate to severe developmental delay, muscular dystrophy, or spinal cord injury).   Persons with immunosuppression, including that caused by medications or by HIV infection. 
  Women who are pregnant or postpartum (within 2 weeks after delivery).
  Persons aged younger than 19 years who are receiving long-term aspirin therapy.
  American Indians/Alaska Natives.
  Persons who are morbidly obese (i.e., body-mass index is equal to or greater than 40).
  Residents of nursing homes and other chronic-care facilities. 

Clinical judgment, on the basis of the patient's disease severity and progression, age, underlying medical conditions, likelihood of influenza, and time since onset of symptoms, is important when making antiviral treatment decisions for high-risk outpatients. 


Additional details regarding antiviral treatment can be found at
http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm

Disease Reporting Requirements/Statute: Several Texas laws (Health & Safety Code. Chapters 81, 84, and 87) require specific information regarding notifiable conditions to be provided to DSHS. Health care providers, hospitals, laboratories, schools, childcare facilities and others are required to report patients who are suspected of having a notifiable condition (Chapter 97, Title 25, Texas Administrative Code).  In Texas, influenza-associated pediatric mortality is required to be reported within one work day. Clusters or outbreaks of any disease, including influenza, should be reported immediately. Reports of influenza-associated pediatric mortality and influenza or influenza-like illness outbreak should be made to your local health department or to 1-800-705-8868.

David Lakey, M.D.
Commissioner
Texas Department of State Health Services

 

 

Some of the initial confusion with the outbreak in Texas came from reports of `negative flu tests’ among some of the patients.   As we’ve discussed often in the past, Rapid Influenza Detection Tests are quick and easy – but they aren’t always accurate (see No Doesn’t Always Mean No).

Hence the reminder by the DSHS (and the CDC, btw) that `a negative RIDT result does NOT exclude a diagnosis of influenza’.

 

For more on the limitations of RIDT tests, you may wish to revisit last year’s side-by-side comparison of 11 commercially available test kits in MMWR: Evaluating RIDTs.

 

With H1N1 prowling the nation, aided and abetted by H3N2 and Influenza B, it is particularly important to maintain good flu hygiene right now.   The CDC recommends:

  • Wash your hands often with soap and water or an alcohol-based hand rub.
  • Avoid touching your eyes, nose, or mouth. Germs spread this way.
  • Try to avoid close contact with sick people.
  • Practice good health habits. Get plenty of sleep and exercise, manage your stress, drink plenty of fluids, and eat healthy food.
  • Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it.
  • If you are sick with flu-like illness, stay home for at least 24 hours after your fever is gone without the use of fever-reducing medicine.

And if you haven’t already gotten your flu shot, it is certainly not too late to do that as well.